Sitting here with my shares, watching the grass grow. Oops, it is brown. I'll check in in about 2 more months to see what is happening. Fraz said it was an ATM. Not so far for me.
Those who panicked sold and are gone. Very little trading today as supply is low. Those holding now understand that the stock is undervalued and are holding not selling. Fundamentals look good for the next few years thus price appreciation for those who wait.
A new equity issue is a possibility. It may not happen as advances from new clients may provide sufficient cash. Any new offering would probably be a small one if required. RGDX may just be going through a temporary lull as more revenue is generated in the coming quarters. The stock is a lot safer to own now after the huge sell off. Small cap stocks are often volatile.
How can you say they are ramping up after this revenue disaster? Whatever Bologna has planned next will cost money and RGDX has none. He will have no choice but to dilute shareholders at $1/share. To be honest, I'm not sure who would be willing to invest anymore $. Talk about being blindsided. I thought worse case scenario was flat revenue for Q3. I'm starting to think more and more that the asset purchase from Pathwork was an act of desperation.
Couldn't agree more. Bologna was talking up future (Q3 and Q4) pharmacy and DX sales in the Q2 CC in August. He should have seen red flags coming at that time, but he kept pumping away and misleading investors. I thought Bologna was the real deal, my bad. Shameful is right! I started selling immediately once revenue numbers came out on Thursday. Quite frankly, I was shocked at the numbers. I could have accepted flat sales, but this was a disaster. This Company is toast. By the way, GHDX reported a 10% increase in DX sales for the quarter. I thought Bologna's excuses were absolutely BS.
Nice, very negative sentiment vs. lukewarm results and a lot of self-flogging by CEO. I like. It's clear they're still ramping up after a long period of research plus the recent acquisition. Mid- and long-term prospects are very interesting, on the short-term, looks artificially oversold by quite a lot. Good luck to you.
Still bleeding...this test is amazing for cancer...it takes time for the revenue to go up...its better to have real approved product than some other #$%$ waiting for fda approval...next year the sales will increase...
RGDX got hammered after a disappointing earnings report. While fundamentals look good it may take months to over a year to gain new customers of scale. The cash position for the company may make some sort of equity issue necessary.
I sold a little on the summer rally and added some back today. Suspect the area of $1.45 to $1.60 will find support. I have been in stocks manged by Mr. Thomas A. Bologna before. He is not flashy but delivers. His M.O. is to build and sell. He is 65 years old so my guess is two to three years of building and the company is sold. accumulate slowly on dips sell some in to rallies but build your position for the final sale.